Quadrant Capital Group LLC Dr Reddys Laboratories LTD Transaction History
Quadrant Capital Group LLC
- $2.65 Billion
- Q1 2025
A detailed history of Quadrant Capital Group LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Quadrant Capital Group LLC holds 155,047 shares of RDY stock, worth $2.14 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
155,047
Previous 172,009
9.86%
Holding current value
$2.14 Million
Previous $2.72 Million
24.71%
% of portfolio
0.08%
Previous 0.19%
Shares
32 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
102MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.12.2MShares$168 Million0.3% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$127 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$125 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$121 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.35MShares$87.8 Million28.64% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.29B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...